Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,763Revenue $M1,302Net Margin (%)11.8Z-Score2.9
Enterprise Value $M6,293EPS $0.3Operating Margin %11.9F-Score6
P/E(ttm))37.6Cash Flow Per Share $1.7Pre-tax Margin (%)9.6Higher ROA y-yY
Price/Book2.110-y EBITDA Growth Rate %6.4Quick Ratio3.6Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %-4.6Current Ratio4.1Lower Leverage y-yN
Price/Cash Flow10.9y-y EBITDA Growth Rate %26.4ROA % (ttm)3.4Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)5.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M233ROI % (ttm)0.4Gross Margin Increase y-yY

Gurus Latest Trades with QGEN

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
QGENRon Baron 2014-03-31 Sold Out $20.46 - $24.82
$ 23.434%Sold Out0
QGENRon Baron 2013-12-31 Reduce$20.63 - $24.65
$ 23.434%Reduce -49%10,200
QGENPRIMECAP Management 2013-09-30 Add0.19%$19.72 - $21.88
$ 23.4312%Add 60.33%17,881,461
QGENPRIMECAP Management 2013-06-30 Add0.06%$18.45 - $21.08
$ 23.4320%Add 22.63%11,152,875
QGENRon Baron 2013-06-30 Reduce$18.45 - $21.08
$ 23.4320%Reduce -45.95%20,000
QGENPRIMECAP Management 2012-09-30 Add0.06%$16.09 - $18.97
$ 23.4333%Add 31.89%8,579,261
QGENPRIMECAP Management 2012-06-30 Buy 0.18%$15 - $17.22
$ 23.4344%New holding, 6504966 sh.6,504,966
QGENRon Baron 2012-03-31 Add$14.49 - $16.76
$ 23.4362%Add 26.98%40,000
QGENRon Baron 2010-12-31 Add$17.02 - $19.92
$ 23.4325%Add 44.23%37,500
QGENRon Baron 2010-09-30 Buy $17.66 - $20.62
$ 23.4325%New holding, 26000 sh.26,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

QGEN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
QGEN PRIMECAP Management 2014-06-3022,087,4049.470.59-0.66%
Premium Most recent portfolio changes are included for Premium Members only!

QGEN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about QGEN :

    Quarterly/Annual Reports about QGEN:

      News about QGEN:

      Articles On GuruFocus.com
      comment on QGEN May 14 2013 
      comment on QGEN May 10 2013 
      Biotech Gets Personal: Long on Qiagen (QGEN) & SPDR S&P Biotech (XBI) Feb 29 2012 
      Guru Stocks at 52-Week Lows: LMT, VIP, VMC, IRM, QGEN Oct 10 2010 
      Weekly Guru Bargains Highlights: QGEN, BXS, ATHR, LYV, TFSL Oct 09 2010 

      More From Other Websites
      Drugmaker AstraZeneca Returns To Growth Aug 05 2014
      Gene Tests to Match Mutations to Drugs Get FDA Oversight Jul 31 2014
      Qiagen Reports In-line Earnings, Beats on Revenues in Q2 Jul 30 2014
      QIAGEN Reports Second Quarter and First Half 2014 Results and Announces Launch of new $100 Million... Jul 29 2014
      AstraZeneca taps Roche, Qiagen for new blood-based cancer drug tests Jul 28 2014
      QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance... Jul 28 2014
      AstraZeneca taps Roche, Qiagen for new blood-based cancer drug tests Jul 28 2014
      QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to... Jul 24 2014
      QIAGEN Advances Leadership in Pre-Analytical Solutions for Next-generation Sequencing (NGS) With... Jul 15 2014
      Qiagen Is Next Deal Candidate With Tax Allure: Real M&A Jul 07 2014
      Qiagen sees rare bullish activity Jun 23 2014
      QIAGEN Receives FDA Approval of artus® CMV RGQ MDx Kit to Monitor Cytomegalovirus (CMV) Viral Load... Jun 18 2014
      QIAGEN and Lilly Collaborate to Co-Develop Companion Diagnostics for Simultaneous Analysis of DNA... May 30 2014
      Qiagen's therascreen KRAS Gets FDA Nod May 28 2014
      Qiagen wins U.S. approval for test to accompany Amgen cancer drug May 23 2014
      Amgen gets expanded approval for colon cancer drug May 23 2014
      QIAGEN receives FDA approval of therascreen KRAS RGQ PCR Kit May 23 2014
      QIAGEN Receives FDA Approval of therascreen® KRAS RGQ PCR Kit Paired with Second Colorectal Cancer... May 23 2014
      Amgen announces FDA approval of Vectibix in combination with FOLFOX May 23 2014
      Lightning Round: Valero, Kinross Gold & More May 22 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial